<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PTX</title>
    <link />
    <description>Headlines for Pernix Therapeutics Holdings, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3604191/update-aegis-capital-lowers-pernix-therapeutics-pt-on-re.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 20 May 2013 12:26:06 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Cantor Fitzgerald Lowers PT on Pernix Therapeutics after Mike Pearce Named CEO</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3591226/update-cantor-fitzgerald-lowers-pt-on-pernix-therapeutic.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 09:01:41 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Reports Loss in 1Q  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99243/pernix-reports-loss-in-1q.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 13 May 2013 14:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Therapeutics Holdings Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1425371-pernix-therapeutics-holdings-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 16:10:04 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Therapeutics Holdings Inc. Stock Downgraded (PTX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11900989/1/pernix-therapeutics-holdings-inc-stock-downgraded-ptx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 22 Apr 2013 05:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Reports Loss in 4Q  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95322/pernix-reports-loss-in-4q.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 21 Mar 2013 13:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3436333/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 21 Mar 2013 10:43:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Canaccord Genuity Cuts PT on Pernix Therapeutics Following Tempered Forecasts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3428814/update-canaccord-genuity-cuts-pt-on-pernix-therapeutics-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Mar 2013 10:47:45 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Cantor Fitzgerald Downgrades Pernix Therapeutics to Hold; Near-Term Appreciation Unlikely</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3427659/update-cantor-fitzgerald-downgrades-pernix-therapeutics-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Mar 2013 08:17:57 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Completes Somaxon Buy - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94494/pernix-completes-somaxon-buy.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 17:57:01 GMT</pubDate>
    </item>
    <item>
      <title>Actavis in Patent Challenge  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94487/actavis-in-patent-challenge.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 16:39:01 GMT</pubDate>
    </item>
    <item>
      <title>Setback for Impax, Shares Plunge - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94180/setback-for-impax-shares-plunge.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 06 Mar 2013 17:55:01 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3395985/pernix-therapeutics-completes-acquisition-of-somaxon-pharmaceuticals.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Mar 2013 16:57:21 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Pernix Therapeutics - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94066/good-news-for-pernix-therapeutics.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 05 Mar 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Therapeutics Receives FDA Approvals</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3377011/pernix-therapeutics-receives-fda-approvals.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 28 Feb 2013 09:01:43 GMT</pubDate>
    </item>
    <item>
      <title>Ram Selvaraju: Fall In Love With These Biotech Stocks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1185981-ram-selvaraju-fall-in-love-with-these-biotech-stocks.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Feb 2013 17:29:14 GMT</pubDate>
    </item>
    <item>
      <title>Teva Enrolls First Patient in Study - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92586/teva-enrolls-first-patient-in-study.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 12 Feb 2013 17:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Perrigo in Expansion Mode - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92579/perrigo-in-expansion-mode.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 12 Feb 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Lannett Beats, Ups Guidance - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92462/lannett-beats-ups-guidance.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Feb 2013 14:24:01 GMT</pubDate>
    </item>
    <item>
      <title>Supernus' Update on Oxtellar - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92373/supernus-update-on-oxtellar.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 08 Feb 2013 16:15:01 GMT</pubDate>
    </item>
  </channel>
</rss>
